Fig. 6: WNK-IN-11 has anti-MM effects in vivo. | Cell Death & Disease

Fig. 6: WNK-IN-11 has anti-MM effects in vivo.

From: Single-cell sequencing analysis of multiple myeloma heterogeneity and identification of new theranostic targets

Fig. 6

A Tumor volume change curve. B The body weights of the mice remained stable. C Fluorescence imaging results of subcutaneous tumors. D Tumor growth differences between groups. E Statistical analysis of the tumor weight data. F Ki67 immunohistochemical staining of tumors from each group was performed. G Statistical analysis of fluorescence intensity data. H Fluorescence imaging showing tumor development after tail vein injection. I Statistical analysis of the fluorescence intensity. J Survival curve of the mice. WNK-IN-low is a low-dose group with a concentration of 1 mg/kg. WNK-IN-high is a low-dose group with a concentration of 5 mg/kg. *p < 0.05, **p < 0.01, ***p < 0.001.

Back to article page